FlexiLingo
FDA Warns GLP-1 Drugs Carry Possible Rare Blindness Risk
- 新闻
- 商业与财经
Plus: Oil prices slide after President Trump suggests new strikes against Iran aren’t likely. And Children’s Place files for bankruptcy. Alex Ossola hosts. Sign up for WSJ’s free What’s News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
打开播放器：完整文字稿，每个单词都可点击，附翻译和单词卡。
这一集适合你吗？
B2 · 中高级
能看懂电视新闻就会觉得轻松
- 87% 的单词在 B1 或更简单的水平。
- 每分钟 174 词：自然语速，偏快。
- 整集共有 17 个较难的单词（B2 及以上）。
试一试：点任意单词
来自本集开头的真实句子，每个单词都标出了难度级别。
I'm Alex Ocela for The Wall Street Journal.
and Zepbound to warn about a rare eye condition that can cause permanent vision loss.
点一个单词，用你的语言查看释义。
这些单词你认识吗？
本集中 8 个较难的单词。点一个查看释义，然后标记一下。
标记几个单词，我们会告诉你这一集是否适合你的水平。
这一集适合你吗？
B2 · 中高级
能看懂电视新闻就会觉得轻松
- 87% 的单词在 B1 或更简单的水平。
- 每分钟 174 词：自然语速，偏快。
- 整集共有 17 个较难的单词（B2 及以上）。
文字稿
本集开头部分。完整文字稿在播放器中。
较难的单词（B2+）
Here's your midday brief for Monday, November 9th. I'm Alex Ocela for The Wall Street Journal. Federal regulators are requiring makers of blockbuster weight loss drugs like Ozempic and Zepbound to warn about a rare eye condition that can cause permanent vision loss.
The FDA says a review of studies on patients taking GLP-1 medications found evidence of a potential increased risk of partial blindness. and Eli Lilly spokeswoman says the company is evaluating the FDA's update. Novo is working with regulators and says that it remains confident the benefits outweigh
the risks of its GLP1s. Lilly and Novo have previously said the studies don't prove that the medications caused the condition. Sanofi, which also has an approved GLP1 drug, didn't immediately respond to a request for
以上是开头部分。 本集其余部分（1 分钟）在播放器中：每个单词都可点击，附翻译、生词收藏和单词卡。
在播放器中继续由音频自动生成，可能存在错误。 音频版权归其发布者所有，并从其订阅源播放。版权所有者可申请删除 — 版权与删除政策